Spectral Diagnostics launches point-of-care Troponin I test at AHA following 510(k) clearance Nov. 8.
This article was originally published in The Gray Sheet
SPECTRAL LAUNCHES CARDIAC STATUS TROPONIN I POC TEST AT $30-35 at the Nov. 11-13 American Heart Association scientific sessions in New Orleans. Exact pricing for the point-of-care qualitative test will vary according to volume ordered, the company says. The Cardiac STATus TnI test was 510(k) cleared by FDA Nov. 8.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.